Physiological Impairments on Respiratory Oscillometry and Future Exacerbations in Chronic Obstructive Pulmonary Disease Patients without a History of Frequent Exacerbations

References

• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2095–2128. DOI:10.1016/S0140-6736(12)61728-0
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Seemungal TA, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10):847–852. DOI:10.1136/thorax.57.10.847
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Wilkinson TM, Hurst JR, et al. Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171(5):446–452. DOI:10.1164/rccm.200408-1054OC
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5):1418–1422. DOI:10.1164/ajrccm.157.5.9709032
   PubMed Web of Science ®Google Scholar
• Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931. DOI:10.1136/thx.2005.040527
   PubMed Web of Science ®Google Scholar
• Hurst JR, Vestbo J, Anzueto A, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. DOI:10.1056/NEJMoa0909883
   PubMed Web of Science ®Google Scholar
• Hoogendoorn M, Feenstra TL, Hoogenveen RT, et al. Association between lung function and exacerbation frequency in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2010;5:435–444. DOI:10.2147/COPD.S13826
   PubMedGoogle Scholar
• Beeh KM, Glaab T, Stowasser S, et al. Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial. Respir Res. 2013;14:116. DOI:10.1186/1465-9921-14-116
   PubMed Web of Science ®Google Scholar
• Kim J, Lee CH, Lee MG, et al. Acute exacerbation according to GOLD 2017 categories in patients with chronic obstructive pulmonary disease. Arch Bronconeumol. 2019;55(8):414–420. DOI:10.1016/j.arbres.2019.02.004
   PubMed Web of Science ®Google Scholar
• Oishi K, Hirano T, Hamada K, et al. Characteristics of 2017 GOLD COPD group A: a multicenter cross-sectional CAP study in Japan. Int J Chron Obstruct Pulmon Dis. 2018;13:3901–3907. DOI:10.2147/COPD.S181938
   PubMed Web of Science ®Google Scholar
• Han MZ, Hsiue TR, Tsai SH, et al. Validation of the GOLD 2017 and new 16 subgroups (1A-4D) classifications in predicting exacerbation and mortality in COPD patients. COPD. 2018; 13:3425–3433. DOI:10.2147/COPD.S179048
   Google Scholar
• Gupta N, Sachdev A, Gupta D. Oscillometry-A reasonable option to monitor lung functions in the era of COVID-19 pandemic. Pediatr Pulmonol. 2021;56(1):14–15. DOI:10.1002/ppul.25121
   PubMed Web of Science ®Google Scholar
• Crim C, Celli B, Edwards LD, ECLIPSE investigators, et al. Respiratory system impedance with impulse oscillometry in healthy and COPD subjects: ECLIPSE baseline results. Respir Med. 2011;105(7):1069–1078. DOI:10.1016/j.rmed.2011.01.010
   PubMed Web of Science ®Google Scholar
• Zimmermann SC, Huvanandana J, Nguyen CD, et al. Day-to-day variability of forced oscillatory mechanics for early detection of acute exacerbations in COPD. Eur Respir J. 2020;56(3):1901739. DOI:10.1183/13993003.01739-2019
   PubMed Web of Science ®Google Scholar
• Tanabe N, Muro S, Hirai T, et al. Impact of exacerbations on emphysema progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;183(12):1653–1659. DOI:10.1164/rccm.201009-1535OC
   PubMed Web of Science ®Google Scholar
• Tanabe N, Sato S, Oguma T, et al. Associations of airway tree to lung volume ratio on computed tomography with lung function and symptoms in chronic obstructive pulmonary disease. Respir Res. 2019;20(1):77. DOI:10.1186/s12931-019-1047-5
   PubMedGoogle Scholar
• Tanimura K, Sato S, Fuseya Y, et al. Quantitative assessment of erector spinae muscles in patients with chronic obstructive pulmonary disease. Novel chest computed tomography-derived index for Prognosis. Ann Am Thorac Soc. 2016;13(3):334–341. DOI:10.1513/AnnalsATS.201507-446OC
   PubMed Web of Science ®Google Scholar
• Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–654. DOI:10.1183/09031936.00102509
   PubMed Web of Science ®Google Scholar
• Tsuda T, Suematsu R, Kamohara K, et al. Development of the Japanese version of the COPD assessment test. Respir Investig. 2012;50(2):34–39. DOI:10.1016/j.resinv.2012.05.003
   PubMedGoogle Scholar
• Miller MR, Hankinson J, Brusasco V, ATS/ERS Task Force, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. DOI:10.1183/09031936.05.00034805
   PubMed Web of Science ®Google Scholar
• Kubota M, Kobayashi H, Quanjer PH, Clinical Pulmonary Functions Committee of the Japanese Respiratory Society, et al. Reference values for spirometry, including vital capacity, in Japanese adults calculated with the LMS method and compared with previous values. Respir Investig. 2014;52(4):242–250. DOI:10.1016/j.resinv.2014.03.003
   PubMedGoogle Scholar
• Mori K, Shirai T, Mikamo M, et al. Colored 3-dimensional analyses of respiratory resistance and reactance in COPD and asthma. Copd. 2011;8(6):456–463. DOI:10.3109/15412555.2011.626818
   PubMedGoogle Scholar
• Berger KI, Wohlleber M, Goldring RM, et al. Respiratory impedance measured using impulse oscillometry in a healthy urban population. ERJ Open Res. 2021;7(1):00560–2020. DOI:10.1183/23120541.00560-2020
   PubMedGoogle Scholar
• Gevenois PA, De Vuyst P, de Maertelaer V, et al. Comparison of computed density and microscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med. 1996;154(1):187–192. DOI:10.1164/ajrccm.154.1.8680679
   PubMed Web of Science ®Google Scholar
• Shimizu K, Tanabe N, Tho NV, et al. Per cent low attenuation volume and fractal dimension of low attenuation clusters on CT predict different long-term outcomes in COPD. Thorax. 2020;75(2):116–122. DOI:10.1136/thoraxjnl-2019-213525
   PubMed Web of Science ®Google Scholar
• Shima H, Tanabe N, Sato S, et al. Lobar distribution of non-emphysematous gas trapping and lung hyperinflation in chronic obstructive pulmonary disease. Respir Investig. 2020;58(4):246–254. DOI:10.1016/j.resinv.2020.01.001
   PubMed Web of Science ®Google Scholar
• Team RC. R: A Language and Environment for Statistical Computing. 2015. Available from: http://www.R-project.org/.
   Google Scholar
• Waschki B, Kirsten A, Holz O, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011;140(2):331–342. DOI:10.1378/chest.10-2521
   PubMed Web of Science ®Google Scholar
• Tanabe N, Sato S, Tanimura K, et al. Associations of CT evaluations of antigravity muscles, emphysema and airway disease with longitudinal outcomes in patients with COPD. Thorax. 2021;76(3):295–297. DOI:10.1136/thoraxjnl-2020-215085
   PubMed Web of Science ®Google Scholar
• Han MK, Kazerooni EA, Lynch DA, COPDGene Investigators, et al. Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology. 2011;261(1):274–282. DOI:10.1148/radiol.11110173
   PubMed Web of Science ®Google Scholar
• Oostveen E, MacLeod D, Lorino H, ERS Task Force on Respiratory Impedance Measurements, et al. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J. 2003;22(6):1026–1041. DOI:10.1183/09031936.03.00089403
   PubMed Web of Science ®Google Scholar
• Shirai T, Kurosawa H. Clinical application of the forced oscillation technique. Intern Med. 2016;55(6):559–566. DOI:10.2169/internalmedicine.55.5876
   PubMed Web of Science ®Google Scholar
• Lundblad LKA, Siddiqui S, Bossé Y, et al. Applications of oscillometry in clinical research and practice. Canadian J Respir Critical Care Sleep Med. 2021;5(1):54–68. DOI:10.1080/24745332.2019.1649607
   Web of Science ®Google Scholar
• Kolsum U, Borrill Z, Roy K, et al. Impulse oscillometry in COPD: identification of measurements related to airway obstruction, airway conductance and lung volumes. Respir Med. 2009;103(1):136–143. DOI:10.1016/j.rmed.2008.07.014
   PubMed Web of Science ®Google Scholar
• Kirby M, Svenningsen S, Kanhere N, et al. Pulmonary ventilation visualized using hyperpolarized helium-3 and xenon-129 magnetic resonance imaging: differences in COPD and relationship to emphysema. J Appl Physiol (1985). 2013;114(6):707–715. DOI:10.1152/japplphysiol.01206.2012
   PubMed Web of Science ®Google Scholar
• Eddy RL, Westcott A, Maksym GN, et al. Oscillometry and pulmonary magnetic resonance imaging in asthma and COPD. Physiol Rep. 2019;7(1):e13955. DOI:10.14814/phy2.13955
   PubMed Web of Science ®Google Scholar
• Kirby M, Pike D, Coxson HO, et al. Hyperpolarized (3)He ventilation defects used to predict pulmonary exacerbations in mild to moderate chronic obstructive pulmonary disease. Radiology. 2014;273(3):887–896. DOI:10.1148/radiol.14140161
   PubMed Web of Science ®Google Scholar
• Aarli BB, Eagan TM, Ellingsen I, et al. Reference values for within-breath pulmonary impedance parameters in asymptomatic elderly. Clin Respir J. 2013;7(3):245–252. DOI:10.1111/j.1752-699X.2012.00312.x
   PubMed Web of Science ®Google Scholar
• Ishii T, Nishimura M, Akimoto A, et al. Understanding low COPD exacerbation rates in Japan: a review and comparison with other countries. Int J Chron Obstruct Pulmon Dis. 2018;13:3459–3471. DOI:10.2147/COPD.S165187
   PubMed Web of Science ®Google Scholar
• Cabrera lópez C, casanova macario C, marín trigo JM, et al. Comparison of the 2017 and 2015 global initiative for chronic obstructive lung disease reports: impact on grouping and outcomes. Am J Respir Crit Care Med. 2018;197(4):463–469. DOI:10.1164/rccm.201707-1363OC
   PubMed Web of Science ®Google Scholar
• Jones PW, Adamek L, Nadeau G, et al. Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification. Eur Respir J. 2013;42(3):647–654. DOI:10.1183/09031936.00125612
   PubMed Web of Science ®Google Scholar
• Kobayashi S, Hanagama M, Ishida M, et al. Clinical characteristics and outcomes in japanese patients with COPD according to the 2017 GOLD classification: the ishinomaki COPD network registry. COPD. 2018;13:3947–3955. DOI:10.2147/COPD.S182905
   Google Scholar
• Zider AD, Wang X, Buhr RG, et al. Reduced COPD exacerbation risk correlates with improved FEV(1): a Meta-Regression analysis. Chest. 2017;152(3):494–501. DOI:10.1016/j.chest.2017.04.174
   PubMed Web of Science ®Google Scholar
• Lutchen KR, Gillis H. Relationship between heterogeneous changes in airway morphometry and lung resistance and elastance. J Appl Physiol (1985). 1997;83(4):1192–1201. DOI:10.1152/jappl.1997.83.4.1192
   PubMed Web of Science ®Google Scholar
• Lundblad LK, Thompson-Figueroa J, Allen GB, et al. Airway hyperresponsiveness in allergically inflamed mice: the role of airway closure. Am J Respir Crit Care Med. 2007;175(8):768–774. DOI:10.1164/rccm.200610-1410OC
   PubMed Web of Science ®Google Scholar
• Mackay AJ, Donaldson GC, Patel AR, et al. Usefulness of the chronic obstructive pulmonary disease assessment test to evaluate severity of COPD exacerbations. Am J Respir Crit Care Med. 2012;185(11):1218–1224. DOI:10.1164/rccm.201110-1843OC
   PubMed Web of Science ®Google Scholar
• Suzuki M, Makita H, Ito YM, Hokkaido COPD Cohort Study Investigators, et al. Clinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort study. Eur Respir J. 2014;43(5):1289–1297. DOI:10.1183/09031936.00110213
   PubMed Web of Science ®Google Scholar
• Putcha N, Anzueto AR, Calverley PMA, et al. Mortality and exacerbation risk by body mass index in patients with COPD in TIOSPIR and UPLIFT. Ann Am Thorac Soc. 2022;19(2):204–213. DOI:10.1513/AnnalsATS.202006-722OC
   PubMed Web of Science ®Google Scholar
• Liang XL, Gao Y, Guan WJ, et al. Reference values of respiratory impedance with impulse oscillometry in healthy chinese adults. J Thorac Dis. 2021;13(6):3680–3691. DOI:10.21037/jtd-20-3376
   PubMed Web of Science ®Google Scholar